Europe faces rising drug-resistant infections due to aging population

Europe could face a significant increase in drug-resistant bloodstream infections by 2050, primarily driven by demographic aging and higher infection rates among male populations, according to new research. A comprehensive study published in PLOS Medicine analyzed over 12 million blood test records from 29 European countries, projecting how antimicrobial resistance patterns may evolve over the coming decades.

Demographic Factors in Infection Rates

The research conducted by the London School of Hygiene & Tropical Medicine indicates that bloodstream infection rates may increase more substantially in men than women across six of eight bacteria monitored by European surveillance networks. The most dramatic increase is projected among older age groups, particularly those over 74 years, highlighting the intersection of demographic change and public health challenges.

Research Methodology and Findings

Scientists examined blood test data collected between 2010 and 2019 to develop projections that account for both age and sex demographics. The study emphasized that antibiotic-resistant bacterial infections represent "a major and growing threat to public health" across European healthcare systems, with aging populations potentially driving increases in both mortality and morbidity related to antimicrobial resistance.

Public Health Implications

The research warned that projections failing to account for demographic differences may substantially underestimate the future burden of drug-resistant infections. Even with robust public health interventions, approximately 32% of the bacteria-antibiotic combinations examined would likely fail to achieve the target of a 10% reduction in infection rates by 2030, indicating significant challenges ahead for European healthcare systems.